Citations (26)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (2)
Masaaki Higashiyama, Ryota Hokari, Chie Kurihara, Toshihide Ueda, Chikako Watanabe, Kengo Tomita, Shunsuke Komoto, Yoshikiyo Okada, Atsushi Kawaguchi, Shigeaki Nagao & Soichiro Miura. (2012) Indomethacin-induced small intestinal injury is ameliorated by cilostazol, a specific PDE-3 inhibitor. Scandinavian Journal of Gastroenterology 47:8-9, pages 993-1002.
Read now
Read now
Masaaki Higashiyama, Ryota Hokari, Hisayuki Matsunaga, Koichi Takebayashi, Chikako Watanabe, Shunsuke Komoto, Yoshikiyo Okada, Chie Kurihara, Atsushi Kawaguchi, Shigeaki Nagao, Kazuro Itoh & Soichiro Miura. (2008) P-Selectin-Dependent Monocyte Recruitment Through Platelet Interaction in Intestinal Microvessels of LPS-Treated Mice. Microcirculation 15:5, pages 441-450.
Read now
Read now
Articles from other publishers (24)
Rosane de Oliveira Lopes, Gabriel Ferreira Lima, Ana Beatriz Araújo Mendes, Lis Jappour Autran, Nikolas Cunha de Assis Pereira, Stephani Correia Brazão, Beatriz Alexandre-Santos, Eliete Dalla Corte Frantz, Christianne Brêtas Vieira Scaramello, Fernanda Carla Ferreira Brito & Nadia Alice Vieira Motta. (2022) Cilostazol attenuates cardiac oxidative stress and inflammation in hypercholesterolemic rats. Naunyn-Schmiedeberg's Archives of Pharmacology 395:7, pages 789-801.
Crossref
Crossref
Lin Zheng, Zhimin Duan, Dingjie Tang, Yanzhi He, Xu Chen, Qing Chen & Min Li. (2021) GP IIb/IIIa-Mediated Platelet Activation and Its Modulation of the Immune Response of Monocytes Against Candida albicans. Frontiers in Cellular and Infection Microbiology 11.
Crossref
Crossref
Daniëlle M. Coenen, Alexandra C. A. Heinzmann, Silvia Oggero, Hugo J. Albers, Magdolna Nagy, Perrine Hagué, Marijke J. E. Kuijpers, Jean-Marie Vanderwinden, Andries D. van der Meer, Mauro Perretti, Rory R. Koenen & Judith M. E. M. Cosemans. (2021) Inhibition of Phosphodiesterase 3A by Cilostazol Dampens Proinflammatory Platelet Functions. Cells 10:8, pages 1998.
Crossref
Crossref
Nadia Alice Vieira Motta, Lis Jappour Autran, Stephani Correia Brazão, Rosane de Oliveira Lopes, Christianne Brêtas Vieira Scaramello, Gabriel Ferreira Lima & Fernanda Carla Ferreira de Brito. (2021) Could cilostazol be beneficial in COVID-19 treatment? Thinking about phosphodiesterase-3 as a therapeutic target. International Immunopharmacology 92, pages 107336.
Crossref
Crossref
Daniela Hernandez, Wee Ming Yeo, Marjory B. Brooks, Sally L. Ness, Thomas J. Divers & Tracy Stokol. (2016) Effects of various antiplatelet drugs on ex vivo platelet activation induced by equine herpesvirus type 1. American Journal of Veterinary Research 77:12, pages 1366-1373.
Crossref
Crossref
Tracy Stokol, Priscila B. D. Serpa, Muhammad N. Zahid & Marjory B. Brooks. (2016) Unfractionated and Low-Molecular-Weight Heparin and the Phosphodiesterase Inhibitors, IBMX and Cilostazol, Block Ex Vivo Equid Herpesvirus Type-1-Induced Platelet Activation. Frontiers in Veterinary Science 3.
Crossref
Crossref
Maria Lukasik & Michal K. Owecki. (2013) Efficacy of Antiplatelet Treatment in Stroke Prevention: Past, Present, and Future. Drug Development Research 74:7, pages 428-439.
Crossref
Crossref
Yasuo Ikeda, Toshiki Sudo & Yukio Kimura. 2013. Platelets. Platelets
1171
1183
.
Michael Sobel. 2013. Platelets. Platelets
699
710
.
Hideki Ito, Kenji Uehara, Yutaka Matsumoto, Ayako Hashimoto, Chifumi Nagano, Manabu Niimi, Goro Miyakoda & Keisuke Nagano. (2012) Cilostazol Inhibits Accumulation of Triglyceride in Aorta and Platelet Aggregation in Cholesterol-Fed Rabbits. PLoS ONE 7:6, pages e39374.
Crossref
Crossref
Theodore Parker, Vipul Davé, Robert Falotico, Jonathon Zhao, Thai Nguyen, Sylvia He, Yi‐Ping Sun & Campbell Rogers. (2012) Control of cilostazol release kinetics and direction from a stent using a reservoir‐based design. Journal of Biomedical Materials Research Part B: Applied Biomaterials 100B:3, pages 603-610.
Crossref
Crossref
Richard Amison, Clive Page & Simon Pitchford. 2012. Antiplatelet Agents. Antiplatelet Agents
447
468
.
Gabriella Passacquale & Albert Ferro. (2011) Current concepts of platelet activation: possibilities for therapeutic modulation of heterotypic vs. homotypic aggregation. British Journal of Clinical Pharmacology 72:4, pages 604-618.
Crossref
Crossref
Hiroki Iida, Mami Iida, Motoyasu Takenaka, Naokazu Fukuoka & Shuji Dohi. (2009) Comparative effects of cilostazol and aspirin on the impairment of endothelium-dependent cerebral vasodilation caused by acute cigarette smoking in rats. Journal of Thrombosis and Thrombolysis 29:4, pages 483-488.
Crossref
Crossref
Hideki Ito, Ayako Hashimoto, Yutaka Matsumoto, Hiroshi Yao & Goro Miyakoda. (2009) Cilostazol, a Phosphodiesterase Inhibitor, Attenuates Photothrombotic Focal Ischemic Brain Injury in Hypertensive Rats. Journal of Cerebral Blood Flow & Metabolism 30:2, pages 343-351.
Crossref
Crossref
Hisayuki Matsunaga, Ryota Hokari, Masaaki Higashiyama, Chie Kurihara, Yoshikiyo Okada, Chikako Watanabe, Shunsuke Komoto, Mitsuyasu Nakamura, Atsushi Kawaguchi, Shigeaki Nagao & Soichiro Miura. (2009) Cilostazol, a specific PDE-3 inhibitor, ameliorates chronic ileitis via suppression of interaction of platelets with monocytes. American Journal of Physiology-Gastrointestinal and Liver Physiology 297:6, pages G1077-G1084.
Crossref
Crossref
M. Cleanthis, V. Bhattacharya, J. Smout, H. Ashour & G. Stansby. (2009) Combined Aspirin and Cilostazol Treatment is Associated with Reduced Platelet Aggregation and Prevention of Exercise-Induced Platelet Activation. European Journal of Vascular and Endovascular Surgery 37:5, pages 604-610.
Crossref
Crossref
Hideki Ito, Mari Fukunaga, Hidenori Suzuki, Goro Miyakoda, Makoto Ishikawa, Youichi Yabuuchi & Waro Taki. (2008) Effect of cilostazol on delayed cerebral vasospasm after subarachnoid hemorrhage in rats: Evaluation using black blood magnetic resonance imaging. Neurobiology of Disease 32:1, pages 157-161.
Crossref
Crossref
D. IWAMA, K. MIYAMOTO, S. MIYAHARA, H. TAMURA, A. TSUJIKAWA, K. YAMASHIRO, J. KIRYU & N. YOSHIMURA. (2007) Neuroprotective effect of cilostazol against retinal ischemic damage via inhibition of leukocyte–endothelial cell interactions. Journal of Thrombosis and Haemostasis 5:4, pages 818-825.
Crossref
Crossref
Victor Serebruany, Alex Malinin, Alex Pokov, Umesh Arora, Dan Atar & Dominick Angiolillo. (2007) Effects of escalating doses of tirofiban on platelet aggregation and major receptor expression in diabetic patients: Hitting the TARGET in the TENACITY trial?. Thrombosis Research 119:2, pages 175-181.
Crossref
Crossref
Yasuo Ikeda, Toshiki Sudo & Yukio Kimura. 2007. Platelets. Platelets
1181
1191
.
Toshiaki Iba, Akio Kidokoro, Masaki Fukunaga, Kitoji Takuhiro, Masakazu Ouchi & Yoshitomo Ito. (2006) COMPARISON OF THE PROTECTIVE EFFECTS OF TYPE III PHOSPHODIESTERASE (PDE3) INHIBITOR (CILOSTAZOL) AND ACETYLSALICYLIC ACID ON INTESTINAL MICROCIRCULATION AFTER ISCHEMIA REPERFUSION INJURY IN MICE. Shock 26:5, pages 522-526.
Crossref
Crossref
Sebastián F. Ameriso, Roberto Lagos, Luis Mariano Ferreira, Lucía Fernández Cisneros & Antonio Ricardo La Mura. (2006) Cerebrovascular Effects of Cilostazol in Patients With Atherosclerotic Disease. Journal of Stroke and Cerebrovascular Diseases 15:6, pages 273-276.
Crossref
Crossref
Jae B. Park & Norberta Schoene. (2006)
Clovamide-Type Phenylpropenoic Acid Amides,
N
-Coumaroyldopamine and
N
-Caffeoyldopamine, Inhibit Platelet-Leukocyte Interactions via Suppressing P-Selectin Expression
. Journal of Pharmacology and Experimental Therapeutics 317:2, pages 813-819.
Crossref
Crossref